380 likes | 488 Views
Flickr/jahdakinebrah. Flickr/Generation X-Ray. Flickr/jahdakinebrah. MSF/Pep Bonet. (more than 30 million are HIV positive). PIH/David Walton. (what makes treatment so expensive?). 32% Marketing and administration. 25% Profits. 30% Operational and material costs. 12% R&D.
E N D
32% Marketing and administration 25% Profits 30% Operational and material costs 12% R&D Pharmaceutical industry expendituresWorldwide, 1996-2005
You bring kindness, and your kindness is good. But it will not cure this AIDS. • I know there is medicine in your country for people like you. But why not here, for people like me?
It is acceptable to die • of a treatable infection • so long as you are poor enough.
Before ARV therapy After six months on ARV therapy PIH/David Walton
$15,000 $15,000 $350 Flickr/MikeBlyth
The University of British Columbia, aspiring to be one of the world’s best universities, will ...prepare students to become exceptional global citizens,promote the values of a civil and sustainable society, andconduct outstanding research to serve the people of British Columbia, Canada, and the world.
Patent Gener-X GlobalAccess Licensing
celebratethe newcampus drug culture • Universities Allied for Essential Medicines • uaem.org
WHO/TDR/Stone CDC/Frank Collins Amphotericin B UBC/Martin Dee Wikimedia Commons
? ? this could be you ? This could be you
celebratethe newcampus drug culture • Universities Allied for Essential Medicines • uaem.org
Add Your Voice – uaem.org • Universities should: • Promoteequal accessto university research • Promote R&D for neglected diseases • Measure success by impact on human welfare
ARV coverage, 2002-2007 WHO/UNAIDS/UNICEF, Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector, Progress Report, June 2008
ARV coverage, 2002-2007 WHO/UNAIDS/UNICEF, Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector, Progress Report, June 2008